Weight loss typically continues, with clinical trials showing that semaglutide 2.4 mg (Wegovy) produces average weight loss of approximately 15% by week 68, while tirzepatide (Zepbound) has demonstrated weight loss of approximately 15-21% across different doses by week 72
This is the same trade-off in reverse: less water raises concentration and shrinks the volume, but also concentrates any measurement error, so the documented volumes in the tables above are the reference point
While highly effective, many patients wonder: does tirzepatide cause loose stools
[1] These medications work by mimicking the action of naturally occurring GLP-1, an incretin hormone that stimulates insulin secretion in response to food intake, suppresses glucagon release, slows gastric emptying, and promotes satiety through central nervous system pathways
Omega-3 Fatty Acids Fatty fish like salmon, flax and chia seeds, nuts, soybean and canola oils, and fortified eggs, juices, and milk are rich in this nutrient